Roth Mkm Reiterates “Buy” Rating for Beyond Air (NASDAQ:XAIR)

Roth Mkm reissued their buy rating on shares of Beyond Air (NASDAQ:XAIR) in a research report released on Friday morning, Benzinga reports. The firm currently has a $2.00 price objective on the stock.

XAIR has been the topic of a number of other reports. BTIG Research lowered shares of Beyond Air from a buy rating to a neutral rating in a research report on Tuesday, June 25th. Truist Financial lowered their price objective on shares of Beyond Air from $10.00 to $8.00 and set a buy rating on the stock in a research report on Tuesday, April 30th. Finally, Piper Sandler reduced their target price on shares of Beyond Air from $3.50 to $1.00 and set an overweight rating for the company in a report on Wednesday, August 7th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of Buy and an average target price of $3.67.

Beyond Air Price Performance

Shares of XAIR opened at $0.47 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 3.80 and a quick ratio of 3.61. Beyond Air has a 1-year low of $0.36 and a 1-year high of $3.35. The stock has a market cap of $21.71 million, a PE ratio of -0.26 and a beta of -0.10. The firm has a fifty day moving average price of $0.70 and a 200 day moving average price of $1.23.

Beyond Air (NASDAQ:XAIR) last posted its earnings results on Tuesday, August 6th. The company reported ($0.27) earnings per share for the quarter, beating the consensus estimate of ($0.39) by $0.12. The business had revenue of $0.68 million during the quarter, compared to the consensus estimate of $0.72 million. Beyond Air had a negative return on equity of 203.12% and a negative net margin of 5,197.76%. During the same period in the previous year, the business earned ($0.45) EPS. As a group, sell-side analysts anticipate that Beyond Air will post -1.01 EPS for the current year.

Insider Activity at Beyond Air

In other news, CEO Steven A. Lisi acquired 100,000 shares of the business’s stock in a transaction on Wednesday, August 14th. The stock was bought at an average price of $0.39 per share, for a total transaction of $39,000.00. Following the transaction, the chief executive officer now owns 1,722,785 shares in the company, valued at $671,886.15. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 19.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Beyond Air

Institutional investors have recently added to or reduced their stakes in the business. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Beyond Air during the 2nd quarter worth approximately $47,000. Rosalind Advisors Inc. acquired a new position in Beyond Air during the first quarter worth $1,572,000. Gendell Jeffrey L raised its position in Beyond Air by 2.8% in the fourth quarter. Gendell Jeffrey L now owns 1,120,297 shares of the company’s stock worth $2,196,000 after acquiring an additional 30,000 shares in the last quarter. Finally, Vanguard Group Inc. lifted its holdings in Beyond Air by 5.0% in the first quarter. Vanguard Group Inc. now owns 1,399,298 shares of the company’s stock valued at $2,435,000 after acquiring an additional 66,224 shares during the period. Hedge funds and other institutional investors own 31.50% of the company’s stock.

About Beyond Air

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.